首页> 外文期刊>British journal of ophthalmology >24-Hour versus daytime intraocular pressure phasing in the management of patients with treated glaucoma.
【24h】

24-Hour versus daytime intraocular pressure phasing in the management of patients with treated glaucoma.

机译:青光眼患者治疗中24小时与白天眼内压的逐步调整。

获取原文
获取原文并翻译 | 示例
       

摘要

AIMS: To determine the value of daytime and 24-h phasing in patients treated for progressive glaucoma despite apparently adequate intraocular pressure (IOP) control. METHODS: A retrospective analysis of a cohort of patients that had undergone either daytime phasing (08:00-18:00) or 24-h phasing was conducted. IOP measurements were compared between those taken in clinic, daytime phasing and 24-h phasing. The frequency with which phasing results changed clinical management was also compared between daytime and 24-h phasing. RESULTS: 76 patients fulfilling the study criteria were identified. Clinic and daytime phasing IOP were known for all 76 patients, nighttime IOP measurements were known for 41. There was no significant difference between mean IOP values measured in clinic and daytime phasing (p=0.062) or between clinic values and nighttime phasing (p=0.65). The mean daytime phasing IOP was significantly higher than the mean nighttime phasing IOP (p=0.038) (analysis of variance (ANOVA) for three groups, p=0.058). There was no significant difference between the mean peak IOP in clinic or daytime phasing (p=0.13) or between clinic and nighttime phasing (p=0.44). The mean daytime phasing IOP peak was significantly higher than the mean nighttime phasing IOP peak (p=0.015) (ANOVA for three groups, p=0.074). There was no significant difference in the frequency of a change in management that occurred as a result of phasing between the daytime and 24-h groups (p=0.65). CONCLUSIONS: 24-H phasing offers little advantage over daytime phasing in the identification of IOP fluctuations or peaks in patients progressing despite acceptable clinic IOP readings. Daytime phasing is likely to be more cost-effective than 24-h phasing.
机译:目的:确定尽管有足够的眼内压(IOP)控制,但进行性青光眼治疗的患者白天和24小时分期的价值。方法:回顾性分析了白天阶段(08:00-18:00)或24小时阶段的患者。在临床,白天分期和24小时分期进行的IOP测量值之间进行了比较。还比较了白天和24小时定相期间定相结果改变临床管理的频率。结果:确定了76例符合研究标准的患者。所有76例患者的临床和白天分阶段IOP已知,夜间IOP测量为41个。临床和白天分阶段(IOP)的平均IOP值之间无显着差异(p = 0.062)或夜间分阶段(P = 0.65)。白天平均分期IOP明显高于夜间平均分期IOP(p = 0.038)(三组的方差分析(ANOVA),p = 0.058)。临床或白天阶段的平均IOP峰值之间(p = 0.13)或临床阶段与夜间阶段的平均IOP峰值之间(p = 0.44)没有显着差异。白天平均IOP峰值明显高于夜间平均IOP峰值(p = 0.015)(三组的ANOVA,p = 0.074)。白天和24小时制组之间的分阶段进行的管理变更频率没有显着差异(p = 0.65)。结论:尽管临床可接受的IOP读数可接受,但24-H阶段在识别IOP波动或峰值的过程中与白天阶段相比几乎没有优势。白天分阶段比24小时分阶段更具成本效益。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号